Author:
Strauch S.,Jantratid E.,Dressman J.B.,Junginger H.E.,Kopp S.,Midha K.K.,Shah V.P.,Stavchansky S.,Barends D.M.
Reference95 articles.
1. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Verapamil hydrochloride, propranolol hydrochloride, and atenolol;Vogelpoel;J Pharm Sci,2004
2. Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms;World Health Organization (WHO),2006
3. Guidance for Industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System;U.S., Department of Health and Human Services, Food and Drug Administration, Center for Evaluation and Research (CDER),2000
4. Committee for Proprietary Medicinal Products (CPMP);European Medicines Agency (EMA),2008
5. Biowaiver monographs for immediate release solid oral dosage forms: Diclofenac sodium and diclofenac potassium;Chuasuwan;J Pharm Sci,2009
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献